{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T07:19:48Z","timestamp":1788592788307,"version":"build-2803163510"},"reference-count":216,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"DHR-ICMR","award":["V.25011\/286-HRD\/2016-HR"],"award-info":[{"award-number":["V.25011\/286-HRD\/2016-HR"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ijbiomac.2018.07.021","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T13:48:36Z","timestamp":1531316916000},"page":"1796-1810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"PB","title":["Protein biomarker for psoriasis: A systematic review on their role in the pathomechanism, diagnosis, potential targets and treatment of psoriasis"],"prefix":"10.1016","volume":"118","author":[{"given":"Krishna","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deependra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju Rawat","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4103\/2229-5178.193906","article-title":"Psoriasis: epidemiology, clinical features, co-morbidities, and clinical scoring","volume":"7","author":"Dogra","year":"2016","journal-title":"Indian Dermatol. Online J."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0015","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1089\/wound.2013.0503","article-title":"Epidermal differentiation in barrier maintenance and wound healing","volume":"3","author":"Wikramanayake","year":"2014","journal-title":"Adv. Wound Care."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1468-3083.2003.00720.x","article-title":"The role of T cells in psoriasis","volume":"17","author":"Prinz","year":"2003","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0025","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1172\/JCI29441","article-title":"Misbehaving macrophages in the pathogenesis of psoriasis","volume":"116","author":"Clark","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/jid.1965.126","article-title":"Autoradiographic analysis of turnover times of normal and psoriatic epidermis","volume":"45","author":"Weinstein","year":"1965","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0035","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4103\/0019-5154.113948","article-title":"A study of various histopathological features and their relevance in pathogenesis of psoriasis","volume":"58","author":"Moorchung","year":"2013","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0040","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212266","article-title":"The cost of biologics for psoriasis is increasing","volume":"3","author":"Cheng","year":"2014","journal-title":"Drugs Context."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0045","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/dth.12267","article-title":"An evolution in switching therapy for psoriasis patients who fail to meet treatment goals","volume":"28","author":"Kerdel","year":"2015","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0050","first-page":"4","article-title":"Signaling molecules as promising drug targets for the treatment of psoriasis, J","volume":"2","author":"Jadali","year":"2015","journal-title":"Ski. Stem Cell."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0055","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jconrel.2013.05.020","article-title":"Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches","volume":"170","author":"Pradhan","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.chemphyslip.2014.11.004","article-title":"Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis","volume":"186","author":"Pradhan","year":"2015","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0065","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3109\/21691401.2014.955105","article-title":"Influence of selected variables on fabrication of triamcinolone acetonide loaded solid lipid nanoparticles for topical treatment of dermal disorders","volume":"44","author":"Pradhan","year":"2016","journal-title":"Artif. Cells, Nanomedicine, Biotechnol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0070","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jddst.2017.07.024","article-title":"Fabrication, optimization and characterization of triamcinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis: application of Box Behnken design, in vitro and ex vivo studies","volume":"41","author":"Pradhan","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0075","doi-asserted-by":"crossref","first-page":"327-327","DOI":"10.1038\/cr.2008.32","article-title":"Cell signaling review series","volume":"18","author":"Lin","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0080","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1016\/j.febslet.2014.02.005","article-title":"Deregulation of cell signaling in cancer","volume":"588","author":"Giancotti","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0085","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.gpb.2015.04.002","article-title":"Biomarkers of an autoimmune skin disease\u2014psoriasis","volume":"13","author":"Jiang","year":"2015","journal-title":"Genomics. Proteomics Bioinformatics."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0090","first-page":"125","article-title":"Study of molecular mechanisms involved in the pathogenesis of immune-mediated inflammatory diseases","author":"Piruzian","year":"2009","journal-title":"using Psoriasis As a Model, Acta Nat."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0095","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri2360","article-title":"WNT signaling in the immune system: WNT is spreading its wings","volume":"8","author":"Staal","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0100","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1158\/1078-0432.CCR-12-0284","article-title":"Molecular pathways: Jak\/STAT pathway: mutations, inhibitors, and resistance","volume":"19","author":"Quintas-Cardama","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrc3893","article-title":"S100 proteins in cancer","volume":"15","author":"Bresnick","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0110","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/ni.3516","article-title":"The itch to degrade ROR-\u03b3t","volume":"17","author":"Rutz","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jid.2016.07.039","article-title":"Spread of psoriasiform inflammation to remote tissues is restricted by the atypical chemokine receptor ACKR2","volume":"137","author":"Shams","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ebiom.2016.10.022","article-title":"Prokineticin 2 plays a pivotal role in psoriasis","volume":"13","author":"He","year":"2016","journal-title":"EBioMedicine."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0125","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.humimm.2017.02.008","article-title":"NFKBIZ in Psoriasis: assessing the association with gene polymorphisms and report of a new transcript variant","volume":"78","author":"Coto-segura","year":"2017","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062347","article-title":"Immunolocalization of the tumor-sensitive calmodulin-like protein CALML3 in normal human skin and hyperproliferative skin disorders","volume":"8","author":"Bennett","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0135","article-title":"Downregulation of TNIP1 expression leads to increased proliferation of human keratinocytes and severer psoriasis-like conditions in an imiquimod-induced mouse model of dermatitis","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0140","doi-asserted-by":"crossref","first-page":"E6162","DOI":"10.1073\/pnas.1606996113","article-title":"Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function","volume":"113","author":"Ippagunta","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076416","article-title":"Karyopherin alpha2 is essential for rRNA transcription and protein synthesis in proliferative keratinocytes","volume":"8","author":"Umegaki-Arao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0150","first-page":"1","article-title":"Expression and functional role of Sox9 in human epidermal keratinocytes","volume":"8","author":"Shi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0155","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1038\/jid.2015.231","article-title":"CCN1, a pro-inflammatory factor, aggravates psoriasis skin lesions by promoting keratinocyte activation","volume":"135","author":"Sun","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0160","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/art.39800","article-title":"Brief report: CXCL10 is a possible biomarker for the development of psoriatic arthritis among patients with psoriasis","volume":"68","author":"Abji","year":"2016","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111255","article-title":"CARD14 expression in dermal endothelial cells in psoriasis","volume":"9","author":"Harden","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0170","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1042\/BCJ20160270","article-title":"Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-kappaB activation","volume":"473","author":"Howes","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0175","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.jaci.2015.09.055","article-title":"The tryptophan metabolism enzyme l-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseases","volume":"137","author":"Harden","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0180","series-title":"Chemerin and Calprotectin Levels Correlate With Disease Activity and Inflammation Markers in Psoriasis Vulgaris","author":"Guzel","year":"2014"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0185","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jdermsci.2015.05.007","article-title":"Leukocyte-derived koebnerisin (S100A15) and psoriasin (S100A7) are systemic mediators of inflammation in psoriasis","volume":"79","author":"Batycka-Baran","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2017.06.003","article-title":"Psoriasis-associated late cornified envelope (LCE) proteins have antibacterial activity","author":"Niehues","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0195","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/ncomms6621","article-title":"The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis","volume":"5","author":"Lande","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0200","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.yexmp.2011.04.015","article-title":"Significance of DC-LAMP and DC-SIGN expression in psoriasis vulgaris lesions","volume":"91","author":"Wei-yuan","year":"2011","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0205","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.advms.2015.07.011","article-title":"CXCL10 in psoriasis","volume":"60","author":"Ferrari","year":"2015","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0210","article-title":"Lack of galanin receptor 3 alleviates psoriasis by altering vascularization, immune cell infiltration and cytokine expression","author":"Locker","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0215","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellsig.2017.02.014","article-title":"GPR43 activation enhances psoriasis-like inflammation through epidermal upregulation of IL-6 and dual oxidase 2 signaling in a murine model","volume":"33","author":"Nadeem","year":"2017","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jdermsci.2017.04.009","article-title":"The proteasome maturation protein POMP increases proteasome assembly and activity in psoriatic lesional skin","volume":"88","author":"Zieba","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11745-016-4211-4","article-title":"Serum fatty acid-binding protein 4 is increased in patients with psoriasis","volume":"52","author":"Baran","year":"2017","journal-title":"Lipids"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0230","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9538451","article-title":"Chitinase-3-like protein 1 (YKL-40) is a new biomarker of inflammation in psoriasis","volume":"2017","author":"Salomon","year":"2017","journal-title":"Mediat. Inflammation,."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0235","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.bor.0000160781.07174.db","article-title":"New strategies for immunosuppression: interfering with cytokines by targeting the Jak\/Stat pathway","volume":"17","author":"O'Shea","year":"2005","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0240","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.4049\/jimmunol.0804063","article-title":"JAK3 inhibition significantly attenuates psoriasiform skin inflammation in CD18 mutant PL\/J mice","volume":"183","author":"Chang","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0245","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1038\/jid.2011.140","article-title":"Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation","volume":"131","author":"Fridman","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0250","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jaad.2011.12.018","article-title":"Preliminary clinical activity of a topical JAK1\/2 inhibitor in the treatment of psoriasis","volume":"67","author":"Punwani","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0255","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/bjd.14399","article-title":"Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study","volume":"174","author":"Ludbrook","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0260","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/stem.170138","article-title":"Functional roles of STAT family proteins: lessons from knockout mice","volume":"17","author":"Akira","year":"1999","journal-title":"Stem Cells"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0265","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.cellsig.2013.05.007","article-title":"Regulation of STAT signaling by acetylation","volume":"25","author":"Zhuang","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0270","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/gut.52.1.144","article-title":"Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets","volume":"52","author":"Hommes","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0275","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00018-008-7440-8","article-title":"The epidermal growth factor receptor family: biology driving targeted therapeutics","volume":"65","author":"Wieduwilt","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0280","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.semcdb.2008.07.003","article-title":"Paradigm shifts in the cell biology of STAT signaling","volume":"19","author":"Sehgal","year":"2008","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20140712","article-title":"The molecular regulation of Janus kinase (JAK) activation","volume":"462","author":"Babon","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0290","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.0022-202X.2003.22113.x","article-title":"In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered","volume":"122","author":"van der Fits","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0002737","article-title":"Type I interferon: potential therapeutic target for psoriasis?","volume":"3","author":"Yao","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0300","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/bjd.12049","article-title":"STAT1 expression and activation is increased in lesional psoriatic skin","volume":"168","author":"Hald","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0305","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.4049\/jimmunol.163.7.3834","article-title":"IFN-\u03b1 activates Stat6 and Leads to the formation of Stat2:Stat6 complexes in B cells","volume":"163","author":"Gupta","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0310","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/107999001750277853","article-title":"The interferon-inducible Stat2:Stat1 heterodimer preferentially binds in vitro to a consensus element found in the promoters of a subset of interferon-stimulated genes","volume":"21","author":"Ghislain","year":"2001","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0315","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0320","doi-asserted-by":"crossref","DOI":"10.4161\/jkst.27521","article-title":"STAT2 and IRF9: beyond ISGF3","volume":"2","author":"Fink","year":"2013","journal-title":"JAK-STAT."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0325","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/nrd1642","article-title":"Psoriasis: STAT3: new target","volume":"4","author":"Brazil","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0330","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2567.2005.02091.x","article-title":"Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas","volume":"114","author":"Mitchell","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0335","series-title":"STATs in Cancer Inflammation and Immunity: A Leading Role for STAT3","first-page":"798","volume":"9","author":"Yu","year":"2009"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0340","doi-asserted-by":"crossref","first-page":"45443","DOI":"10.1074\/jbc.M107527200","article-title":"Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation","volume":"276","author":"Turkson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0345","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1158\/1535-7163.261.3.3","article-title":"Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity","volume":"3","author":"Turkson","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0350","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/cancers6020926","article-title":"Transcription factor STAT3 as a novel molecular target for cancer prevention","volume":"6","author":"Xiong","year":"2014","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0355","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nri1226","article-title":"Regulation of JAK-STAT signalling in the immune system","volume":"3","author":"Shuai","year":"2003","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0360","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015354","article-title":"Psoriasis","volume":"4","author":"Di Meglio","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0365","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","article-title":"Interferon\u2013inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3","volume":"187","author":"Cole","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0370","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1471-4906(00)01812-3","article-title":"RANTES: a versatile and controversial chemokine","volume":"22","author":"Appay","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0176994","article-title":"STAT2 is involved in the pathogenesis of psoriasis by promoting CXCL11 and CCL5 production by keratinocytes","volume":"12","author":"Johansen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0380","first-page":"198","article-title":"S100 protein family and its application in clinical practice","volume":"12","author":"Sedaghat","year":"2008","journal-title":"Hippokratia."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0385","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/002215540305100513","article-title":"S100 protein subcellular localization during epidermal differentiation and psoriasis","volume":"51","author":"Broome","year":"2003","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0390","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/jid.2009.206","article-title":"Significance of the S100A4 protein in psoriasis","volume":"130","author":"Zibert","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0395","article-title":"S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma","volume":"12","author":"Maletzki","year":"2012","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0400","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.0022-202X.2004.22719.x","article-title":"S100 proteins in the epidermis","volume":"123","author":"Eckert","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0405","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/1523-1747.ep12484041","article-title":"Molecular cloning, occurrence, and expression of a novel partially secreted protein \u201cpsoriasin\u201d that is highly up-regulated in psoriatic skin","volume":"97","author":"Madsen","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0410","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0022-5347(01)66118-4","article-title":"Bladder squamous cell carcinomas express psoriasin and externalize it to the urine","volume":"155","author":"Celis","year":"1996","journal-title":"J. Urol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0415","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0002-9440(10)65524-1","article-title":"Psoriasin (S100A7) expression and invasive breast cancer","volume":"155","author":"Al-Haddad","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0420","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1523-1747.ep12294284","article-title":"Psoriasin: a novel chemotactic protein","volume":"107","author":"Jinquan","year":"1996","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0425","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/jid.2011.486","article-title":"Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 \u201calarmins\u201d psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis","volume":"132","author":"Hegyi","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0430","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10549-011-1920-5","article-title":"Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation","volume":"134","author":"Shubbar","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0435","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.0906-6705.2005.00239.x","article-title":"Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation","volume":"14","author":"Martinsson","year":"2005","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0440","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/BF00197417","article-title":"Refined mapping of the psoriasin gene S100A7 to chromosome 1cen-q21","volume":"96","author":"Borglum","year":"1995","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0445","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0888-7543(95)80005-7","article-title":"Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family","volume":"25","author":"Schafer","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0450","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/1523-1747.ep12338501","article-title":"Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex (\u201cepidermal differentiation complex\u201d) on human chromosome 1q21","volume":"106","author":"Mischke","year":"1996","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0455","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2340\/00015555-2596","article-title":"Overexpression of psoriasin (S100A7) contributes to dysregulated differentiation in psoriasis","volume":"97","author":"Ekman","year":"2017","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0169788","article-title":"Human S100A7 induces mature interleukin1\u03b1 expression by RAGE-p38 MAPK-Calpain1 pathway in psoriasis","volume":"12","author":"Lei","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0465","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.4049\/jimmunol.171.5.2602","article-title":"Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide","volume":"171","author":"Vandal","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0470","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1471-4906(03)00062-0","article-title":"Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules","volume":"24","author":"Roth","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0475","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.immuni.2013.11.011","article-title":"S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3","volume":"39","author":"Schonthaler","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0480","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/0300060515598900","article-title":"S100A8\/A9 in psoriatic plaques from patients with psoriatic arthritis","volume":"44","author":"Chimenti","year":"2016","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0485","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/00365540310017294","article-title":"Serum S100B levels in patients with cerebral and extracerebral infectious disease","volume":"36","author":"Unden","year":"2004","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0490","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jdermsci.2007.07.005","article-title":"Increased S100B protein serum levels in psoriasis","volume":"48","author":"Paradisi","year":"2007","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0495","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.brainres.2004.01.028","article-title":"Relationship between stress and circulating levels of S100B protein","volume":"1004","author":"Scaccianoce","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0500","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbamcr.2008.11.009","article-title":"S100B's double life: intracellular regulator and extracellular signal","volume":"1793","author":"Donato","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0505","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1189\/jlb.1207832","article-title":"Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase","volume":"84","author":"Omori","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0510","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2174\/156652407783220688","article-title":"RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins","volume":"7","author":"Donato","year":"2007","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.120568","article-title":"The immunologic basis for the treatment of psoriasis with new biologic agents","volume":"46","author":"Krueger","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0520","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cytogfr.2006.09.006","article-title":"Waste management - cytokines, growth factors and cachexia","volume":"17","author":"Saini","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0525","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1590\/abd1806-4841.20175038","article-title":"Study of serum levels and skin expression of S100B protein in psoriasis","volume":"92","author":"Salem","year":"2017","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-5945-3-1","article-title":"Psoriasin (S100A7) expression is altered during skin tumorigenesis","volume":"3","author":"Alowami","year":"2003","journal-title":"BMC Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0535","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.3390\/ijms140610869","article-title":"Epidermal development in mammals: key regulators, signals from beneath, and stem cells","volume":"14","author":"Liu","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8050050","article-title":"Frizzled7: a promising Achilles' heel for targeting the Wnt receptor complex to treat cancer","volume":"8","author":"Phesse","year":"2016","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0545","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1046\/j.1523-1747.2001.01336.x","article-title":"Characterization of mouse Frizzled-3 expression in hair follicle development and identification of the human homolog in keratinocytes","volume":"116","author":"Hung","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0005354","article-title":"Wnt5a exhibits layer-specific expression in adult skin, is upregulated in psoriasis, and synergizes with type 1 interferon","volume":"4","author":"Romanowska","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0555","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.0022-202X.2005.23864.x","article-title":"Increased sensitivity to interferon-alpha in psoriatic T cells","volume":"125","author":"Eriksen","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0560","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2005-12-5046","article-title":"The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation","volume":"108","author":"Blumenthal","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0079253","article-title":"Modulation of epidermal transcription circuits in psoriasis: new links between inflammation and hyperproliferation","volume":"8","author":"Swindell","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0570","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0575","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/sj.jid.5701255","article-title":"Polymorphisms of the IL12B and IL23R genes are associated with psoriasis","volume":"128","author":"Nair","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0019806","article-title":"GATA3 expression is decreased in psoriasis and during epidermal regeneration; induction by narrow-band UVB and IL-4","volume":"6","author":"R\u00e1cz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0585","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1038\/jid.2010.67","article-title":"Evidence for altered Wnt signaling in psoriatic skin","volume":"130","author":"Gudjonsson","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0590","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5021\/ad.2016.28.1.45","article-title":"Interaction of Wnt5a with Notch1 is critical for the pathogenesis of psoriasis","volume":"28","author":"Kim","year":"2016","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0595","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1365-2567.1998.00440.x","article-title":"Kinetics of cytokine and NFAT gene expression in human interleukin-2-dependent T lymphoblasts stimulated via T-cell receptor","volume":"93","author":"Sareneva","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0600","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.imbio.2012.01.012","article-title":"Down-regulation of interleukin-2 production by CD4+ T cells expressing TIM-3 through suppression of NFAT dephosphorylation and AP-1 transcription","volume":"217","author":"Lee","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0605","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.jid.5700943","article-title":"PPAR\u03b4 enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor","volume":"128","author":"Romanowska","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0009701","article-title":"Activation of PPAR\u03b2\/\u03b4 causes a psoriasis-like skin disease in vivo","volume":"5","author":"Romanowska","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0615","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0344-0338(96)80088-4","article-title":"The role of p53 in cell cycle regulation","volume":"192","author":"Shaw","year":"1996","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0620","first-page":"79","article-title":"Expression of p53 protein in psoriasis","volume":"14","author":"Baran","year":"2005","journal-title":"Acta Dermatovenerologica Alpina, Pannonica, Adriat."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0625","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/sj.onc.1210296","article-title":"Mutant p53: an oncogenic transcription factor","volume":"26","author":"Strano","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0630","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.18632\/oncotarget.13475","article-title":"The role of p53 in cancer drug resistance and targeted chemotherapy","volume":"8","author":"Hientz","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0635","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.dnarep.2004.03.027","article-title":"The p53 response to {DNA} damage","volume":"3","author":"Meek","year":"2004","journal-title":"DNA Repair"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0640","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/jcb.21091","article-title":"p53 modulation of the DNA damage response","volume":"100","author":"Helton","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0645","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026070","article-title":"p53 in the DNA damage repair process","volume":"6","author":"Williams","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0650","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1346-8138.2007.00290.x","article-title":"Expression of p53 in lesions and unaffected skin of patients with plaque-type and guttate psoriasis: a quantitative comparative study","volume":"34","author":"Yazici","year":"2007","journal-title":"J. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0655","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4103\/0377-4929.168861","article-title":"Expression of apoptosis regulating proteins p53 and bcl-2 in psoriasis","volume":"58","author":"Moorchung","year":"2015","journal-title":"Indian J. Pathol. Microbiol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0660","series-title":"Cell A Mol. Approach","article-title":"The central role of enzymes as biological catalysts","author":"Cooper","year":"2000"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0665","first-page":"777","article-title":"Enzymes in clinical medicine: an overview","volume":"51","author":"Hemalatha","year":"2013","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0670","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.3390\/ijms14046720","article-title":"Cytokines and the skin barrier","volume":"14","author":"H\u00e4nel","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0675","series-title":"Epidermal CD147 Expression Plays a Key Role in IL-22-Induced Psoriatic Dermatitis","first-page":"1","author":"Peng","year":"2017"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0680","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1172\/JCI115854","article-title":"Adenosine triphosphate stimulates phosphoinositide metabolism, mobilizes intracellular calcium, and inhibits terminal differentiation of human epidermal keratinocytes","volume":"90","author":"Pillai","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0685","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1091\/mbc.e05-02-0109","article-title":"Calcium-induced human keratinocyte differentiation requires src- and fyn-mediated phosphatidylinositol 3-kinase\u2013dependent activation of phospholipase C-\u03b31","volume":"16","author":"Xie","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0690","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.beem.2013.03.002","article-title":"Role of the calcium-sensing receptor in calcium regulation of epidermal differentiation and function","volume":"27","author":"Tu","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0695","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/1523-1747.ep12469836","article-title":"Partial characterization of phospholipase C activity in normal, psoriatic uninvolved, and Lesional epidermis","volume":"88","author":"Bartel","year":"1987","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0700","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1084\/jem.20160258","article-title":"Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a","volume":"213","author":"Cheung","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0705","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/cdd.2017.56","article-title":"Phospholipase C[delta]1 regulates p38 MAPK activity and skin barrier integrity","volume":"24","author":"Kanemaru","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0710","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","article-title":"Cytokines in psoriasis","volume":"73","author":"Baliwag","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0715","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9259646","article-title":"Biologics for targeting inflammatory cytokines, clinical uses, and limitation","author":"Rider","year":"2016","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1357-2725(01)00097-8","article-title":"Tumor necrosis factor-alpha converting enzyme","volume":"34","author":"Black","year":"2002","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0725","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1111\/j.1432-1033.2004.04215.x","article-title":"Tumour necrosis factor-alpha stimulates expression of TNF-alpha converting enzyme in endothelial cells","volume":"271","author":"Bzowska","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0730","doi-asserted-by":"crossref","first-page":"ra34","DOI":"10.1126\/scisignal.2002689","article-title":"TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association","volume":"5","author":"Xu","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0735","series-title":"New Insights of T cells in the Pathogenesis of Psoriasis","first-page":"302","author":"Cai","year":"2012"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0740","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.tips.2006.03.010","article-title":"TACE-dependent EGF receptor activation in angiotensin-II-induced kidney disease","volume":"27","author":"Shah","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0745","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1158\/1078-0432.CCR-07-1216","article-title":"TACE\/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer","volume":"14","author":"Merchant","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0750","series-title":"Involvement of TNF - A Converting Enzyme in the Development of Psoriasis-Like Lesions in a Mouse Model","volume":"9","author":"Sato","year":"2014"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0755","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.bmcl.2017.02.035","article-title":"Identification of novel {TACE} inhibitors compatible with topical application","volume":"27","author":"Ouvry","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0760","article-title":"Discovery and process development of a novel {TACE} inhibitor for the topical treatment of psoriasis","author":"Boiteau","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0765","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1365-2230.2009.03410.x","article-title":"A comprehensive review of biomarkers in psoriasis","volume":"34","author":"Rashmi","year":"2009","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0770","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.gpb.2015.04.002","article-title":"Biomarkers of an autoimmune skin disease\u2013psoriasis","volume":"13","author":"Jiang","year":"2015","journal-title":"Genomics. Proteomics Bioinformatics."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0775","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-4889(96)00172-3","article-title":"Differential expression of proteins regulating cell cycle progression in growth vs. differentiation","volume":"1356","author":"Li","year":"1997","journal-title":"Biochim. Biophys. Acta - Mol. Cell Res."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0780","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/eji.201242740","article-title":"Small molecule inhibitors of RORgammat: targeting Th17 cells and other applications","volume":"42","author":"Huh","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0785","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.smim.2007.10.011","article-title":"Transcriptional regulation of Th17 cell differentiation","volume":"19","author":"Ivanov","year":"2007","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0790","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","article-title":"TH17 lineage differentiation is programmed by orphan nuclear receptors ROR\u03b1 and ROR\u03b3","volume":"28","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0795","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ni.1610","article-title":"The differentiation of human T(H)-17 cells requires transforming growth factor-\u03b2 and induction of the nuclear receptor ROR\u03b3T","volume":"9","author":"Manel","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0800","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri1807","article-title":"Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells","volume":"6","author":"Dong","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0805","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/701094","article-title":"Overexpression and selectively regulatory roles of IL-23\/IL-17 axis in the lesions of oral lichen planus","volume":"2014","author":"Lu","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0810","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0815","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/08916934.2016.1166214","article-title":"New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis","volume":"49","author":"Karczewski","year":"2016","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0820","series-title":"Methylene Linked Quinolinyl Modulators of ROR-Gamma-t","author":"Leonard","year":"2014"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0825","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature09978","article-title":"Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity","volume":"472","author":"Huh","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0830","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nature10075","article-title":"Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand","volume":"472","author":"Solt","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0835","doi-asserted-by":"crossref","first-page":"22707","DOI":"10.1074\/jbc.C111.250407","article-title":"Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORgamma t protein","volume":"286","author":"Xu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0840","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2014.04.005","article-title":"The emerging landscape of ROR\u03b3t biology","volume":"40","author":"Lee","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0845","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.immuni.2014.04.004","article-title":"Small-molecule RORgammat antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms","volume":"40","author":"Xiao","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0850","doi-asserted-by":"crossref","DOI":"10.1038\/srep37977","article-title":"Pharmacologic modulation of RORgammat translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis","volume":"6","author":"Xue","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0855","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0860","series-title":"REV-ERB and ROR Nuclear Receptors as Drug Targets","first-page":"197","volume":"13","author":"Kojetin","year":"2014"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0865","first-page":"1","article-title":"Development of a topical treatment for psoriasis targeting ROR\u03b3: from bench to skin","volume":"11","author":"Smith","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0870","series-title":"ROR\u03b3, a Hot Target for Treatment of Th17 cell-Mediated Immune Diseases, But Also for Immune Therapy of Cancer","year":"2016"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0875","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1359-6101(03)00019-4","article-title":"TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR\/Fn14 receptor","volume":"14","author":"Wiley","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0880","doi-asserted-by":"crossref","first-page":"32401","DOI":"10.1074\/jbc.272.51.32401","article-title":"TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis","volume":"272","author":"Chicheportiche","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0885","first-page":"780","article-title":"Expression of TWEAK in normal human skin, dermatitis and epidermal neoplasms: association with proliferation and differentiation of keratinocytes","volume":"38","author":"Peternel","year":"2011","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0890","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2007.09.007","article-title":"TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK\/Fn14 pathway in health and disease","volume":"40","author":"Burkly","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0895","doi-asserted-by":"crossref","first-page":"15395","DOI":"10.1038\/ncomms15395","article-title":"TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis","volume":"8","author":"Sidler","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0033609","article-title":"TWEAK affects keratinocyte G2\/M growth arrest and induces apoptosis through the translocation of the AIF protein to the nucleus","volume":"7","author":"Sabour Alaoui","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0905","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cyto.2010.12.003","article-title":"Increased serum TWEAK levels in psoriatic arthritis: relationship with disease activity and matrix metalloproteinase-3 serum levels","volume":"53","author":"Xia","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0910","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cyto.2015.10.004","article-title":"Serum levels of TWEAK in patients with psoriasis vulgaris","volume":"77","author":"Bilgic","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0915","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cyto.2012.06.285","article-title":"TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis","volume":"60","author":"Park","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0920","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.clinthera.2013.06.008","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of anti-TWEAK monoclonal antibody in patients with rheumatoid arthritis","volume":"35","author":"Wisniacki","year":"2013","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0925","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/jid.2008.70","article-title":"Roles of aquaporin-3 in the epidermis","volume":"128","author":"Hara-Chikuma","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0930","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1177\/002215549904701007","article-title":"Water channel protein AQP3 is present in epithelia exposed to the environment of possible water loss","volume":"47","author":"Matsuzaki","year":"1999","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0935","doi-asserted-by":"crossref","first-page":"46616","DOI":"10.1074\/jbc.M209003200","article-title":"Selectively reduced glycerol in skin of aquaporin-3-deficient mice may account for impaired skin hydration, elasticity, and barrier recovery","volume":"277","author":"Hara","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0940","doi-asserted-by":"crossref","first-page":"16140","DOI":"10.1074\/jbc.272.26.16140","article-title":"Water and glycerol permeabilities of aquaporins 1-5 and MIP determined quantitatively by expression of epitope-tagged constructs in Xenopus oocytes","volume":"272","author":"Yang","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0945","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1073\/pnas.1230416100","article-title":"Glycerol replacement corrects defective skin hydration, elasticity, and barrier function in aquaporin-3-deficient mice","volume":"100","author":"Hara","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0950","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00109-007-0272-4","article-title":"Aquaporin-3 facilitates epidermal cell migration and proliferation during wound healing","volume":"86","author":"Hara-Chikuma","year":"2008","journal-title":"J. Mol. Med. (Berl)."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0955","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/MCB.01482-07","article-title":"Prevention of skin tumorigenesis and impairment of epidermal cell proliferation by targeted aquaporin-3 gene disruption","volume":"28","author":"Hara-Chikuma","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0960","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5021\/ad.2001.13.1.7","article-title":"Changes of transepidermal water loss (TEWL) in psoriatic plaques during D-PUVA therapy","volume":"13","author":"Hun Suh","year":"2001","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0965","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1440-0960.2010.00629.x","article-title":"Aquaporin-3 gene and protein expression in sun-protected human skin decreases with skin ageing","volume":"51","author":"Li","year":"2010","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0970","doi-asserted-by":"crossref","first-page":"17147","DOI":"10.1074\/jbc.M200925200","article-title":"Impaired stratum corneum hydration in mice lacking epidermal water channel aquaporin-3","volume":"277","author":"Ma","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0975","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/BC20040104","article-title":"Aquaporin-3 functions as a glycerol transporter in mammalian skin","volume":"97","author":"Hara-Chikuma","year":"2005","journal-title":"Biol. Cell."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0980","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5021\/ad.2012.24.2.168","article-title":"Changes in transepidermal water loss and skin hydration according to expression of Aquaporin-3 in psoriasis","volume":"24","author":"Lee","year":"2012","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0985","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbrc.2009.07.077","article-title":"Tumor necrosis factor-alpha decreases aquaporin-3 expression in DJM-1 keratinocytes","volume":"387","author":"Horie","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0990","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/jid.2010.395","article-title":"Upregulation of aquaporin-3 is involved in keratinocyte proliferation and epidermal hyperplasia","volume":"131","author":"Nakahigashi","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb0995","first-page":"6239","article-title":"The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells","volume":"59","author":"Gong","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb1000","series-title":"Cold Spring Harb","article-title":"Essentials of glycobiology","author":"Varki","year":"2009"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb1005","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1017\/S1462399408000719","article-title":"Galectins: structure, function and therapeutic potential","volume":"10","author":"Yang","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb1010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0625.1994.tb00260.x","article-title":"Expression of epsilon BP, a beta-galactoside-binding soluble lectin, in normal and neoplastic epidermis","volume":"3","author":"Konstantinov","year":"1994","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb1015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jdermsci.2011.07.008","article-title":"Galectin-3 and the skin","volume":"64","author":"Larsen","year":"2011","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb1020","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbagen.2005.12.020","article-title":"Galectin-3: an open-ended story","volume":"1760","author":"Dumic","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb1025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2011.09.003","article-title":"Galectin-3\u2013a jack-of-all-trades in cancer","volume":"313","author":"Newlaczyl","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb1030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/path.3996","article-title":"Psoriasis in humans is associated with down-regulation of galectins in dendritic cells","volume":"228","author":"de la Fuente","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb1035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14712\/fb2006052010010","article-title":"Glycophenotype of psoriatic skin","volume":"52","author":"Lacina","year":"2006","journal-title":"Folia Biol. (Praha)."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb1040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/art.38891","article-title":"Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus","volume":"67","author":"Shi","year":"2015","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb1045","article-title":"Decrease of galectin-3 in keratinocytes: a potential diagnostic marker and a critical contributor to the pathogenesis of psoriasis","author":"Shi","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb1050","doi-asserted-by":"crossref","DOI":"10.1517\/14728214.2012.672559","article-title":"Amyloid beta (Abeta) peptide modulators and other current treatment strategies for Alzheimer's disease (AD)","author":"Lukiw","year":"2012","journal-title":"Expert Opin. Emerg. Drugs."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb1055","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jnc.12675","article-title":"Insights into the physiological function of the beta-amyloid precursor protein: beyond Alzheimer's disease","volume":"129","author":"Dawkins","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb1060","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.0022-202X.2004.23320.x","article-title":"Normalized proliferation of normal and psoriatic keratinocytes by suppression of sAPP\u03b1-release","volume":"123","author":"Siemes","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb1065","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2012.00005","article-title":"Association of skin with the pathogenesis and treatment of neurodegenerative amyloidosis","volume":"3","author":"Clos","year":"2012","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb1070","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1073\/pnas.93.7.2749","article-title":"Batimastat, a potent matrix metalloproteinase inhibitor, exhibits an unexpected mode of binding","volume":"93","author":"Botos","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb1075","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/j.1471-4159.2007.04685.x","article-title":"Enhancement of alpha-secretase cleavage of amyloid precursor protein by a metalloendopeptidase nardilysin","volume":"102","author":"Hiraoka","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2018.07.021_bb1080","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1078\/0171-9335-00401","article-title":"Biological roles of APP in the epidermis","volume":"83","author":"Herzog","year":"2004","journal-title":"Eur. J. Cell Biol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813018320750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813018320750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T07:10:37Z","timestamp":1758870637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813018320750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":216,"alternative-id":["S0141813018320750"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.07.021","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein biomarker for psoriasis: A systematic review on their role in the pathomechanism, diagnosis, potential targets and treatment of psoriasis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}